Pyloric stenosis associated Crohn's disease responding to adalimumab therapy | Zendy

Sameer Gaggar | Zendy; John Scott | Zendy; Nicholas J. Thompson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pyloric stenosis associated Crohn's disease responding to adalimumab therapy

Author(s) -

Sameer Gaggar,

John Scott,

Nicholas J. Thompson

Publication year - 2012

Publication title -

world journal of gastrointestinal pharmacology and therapeutics

Language(s) - Uncategorized

Resource type - Journals

ISSN - 2150-5349

DOI - 10.4292/wjgpt.v3.i6.97

Subject(s) - medicine , adalimumab , crohn's disease , medical therapy , necrosis , disease , stenosis , infliximab , tumor necrosis factor alpha , pyloric stenosis , gastroenterology , surgery

Gastroduodenal Crohn's disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research